Works matching IS 00139580 AND DT 2013 AND VI 54 AND IP 1


Results: 31
    1
    2
    3

    Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy.

    Published in:
    Epilepsia (Series 4), 2013, v. 54, n. 1, p. e9, doi. 10.1111/j.1528-1167.2012.03654.x
    By:
    • Eftekhari, Sanaz;
    • Mehvari Habibabadi, Jafar;
    • Najafi Ziarani, Massoumeh;
    • Hashemi Fesharaki, Seyed Sohrab;
    • Gharakhani, Marzieh;
    • Mostafavi, Hossein;
    • Joghataei, Mohammad Taghi;
    • Beladimoghadam, Nahid;
    • Rahimian, Elham;
    • Hadjighassem, Mahmoud Reza
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies.

    Published in:
    Epilepsia (Series 4), 2013, v. 54, n. 1, p. 98, doi. 10.1111/j.1528-1167.2012.03605.x
    By:
    • Gil‐Nagel, António;
    • Elger, Christian;
    • Ben‐Menachem, Elinor;
    • Halász, Peter;
    • Lopes‐Lima, José;
    • Gabbai, Alberto A.;
    • Nunes, Teresa;
    • Falcão, Amílcar;
    • Almeida, Luis;
    • Soares‐da‐Silva, Patrício
    Publication type:
    Article
    18
    19
    20

    Dramatic weight loss with rufinamide.

    Published in:
    Epilepsia (Series 4), 2013, v. 54, n. 1, p. e5, doi. 10.1111/j.1528-1167.2012.03579.x
    By:
    • Mourand, Isabelle;
    • Crespel, Arielle;
    • Gelisse, Philippe
    Publication type:
    Article
    21
    22
    23
    24
    25

    Antiepileptic drugs and the fetal epigenome.

    Published in:
    Epilepsia (Series 4), 2013, v. 54, n. 1, p. e16, doi. 10.1111/j.1528-1167.2012.03673.x
    By:
    • Emes, Richard D.;
    • Clifford, Harry;
    • Haworth, Kim E.;
    • Farrell, William E.;
    • Fryer, Anthony A.;
    • Carroll, William D.;
    • Ismail, Khaled M. K.
    Publication type:
    Article
    26
    27
    28

    Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307.

    Published in:
    Epilepsia (Series 4), 2013, v. 54, n. 1, p. 126, doi. 10.1111/j.1528-1167.2012.03648.x
    By:
    • Krauss, Gregory L.;
    • Perucca, Emilio;
    • Ben‐Menachem, Elinor;
    • Kwan, Patrick;
    • Shih, Jerry J.;
    • Squillacote, David;
    • Yang, Haichen;
    • Gee, Michelle;
    • Zhu, Jin;
    • Laurenza, Antonio
    Publication type:
    Article
    29
    30
    31